Clinical Trials for Mesothelioma Patients: Vorinostat vs. Placebo Contact Information

Read more here to obtain contact information for the current clinical trial being conducted to study Vorinostat in patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Locations:

USA:
Pittsburgh, PA 15232
1-888-577-8839

Belgium:
Merck Sharp & Dohme B.V.
Bruxelles, Belgium, 1180
Contact: Nathalie Schrameijer
32-2-373-4310

Germany:
Msd Sharp & Dohme Gmbh
Haar, Germany, 85540
Contact: Thomas Lang
49-89-4561-1536

Netherlands:
Merck Sharp & Dohme B.V.
Haarlem, Netherlands, 2031 BN
Contact: Gerard Van Leijenhorst
31 23 515 3306

New Zealand:
Merck Sharp & Dohme (New Zealand) Ltd.
Auckland, New Zealand
Contact: David Woolner
64-9523-6075

Spain:
Merck Sharp & Dohme De Espana, S.A.E.
Madrid, Spain, 28027
Contact: Jorge Gonzalez-Esteban
34 91 3210726

Sweden:
Merck Sharp & Dohme (Sweden) AB
Sollentuna, Sweden, 192 07
Contact: Roger Juhlin
46-8-626-1 458

United Kingdom, Hertfordshire
Merck Sharp & Dohme Ltd.
Hoddesdon, Hertfordshire, United Kingdom, EN11 9BU
Contact: Paul Robinson
44 1992 452341

If you or a loved one has been diagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.